BREAKING NEWS

BREAKING NEWS

Drugmakers Amneal and Impax to combine

Now Reading:

Drugmakers Amneal and Impax to combine

Text size Aa Aa

(Reuters) – Privately-held generic drugmaker Amneal Pharmaceuticals LLC and peer Impax Laboratories Inc <IPXL.O> said on Tuesday they would combine in an all-stock transaction. Amneal Holdings’ members will own about 75 percent and Impax shareholders will own 25 percent of the new company’s pro forma shares.

(Reporting by Manas Mishra in Bengaluru; Editing by Martina D’Couto)
euronews provides breaking news articles from reuters as a service to its readers, but does not edit the articles it publishes. Articles appear on euronews.com for a limited time.